Sign up for access to exclusive content, events, materials and updates from OWL.
Rarely will you find a value as great as an OWL membership! By becoming a member you establish yourself as committed to "Advancing Diversity in Leadership" and in standing as a leader for today's world. You'll also be affiliated with the best and brightest in Ophthalmology. Take a look here at some of our Champion members!
LEARN MOREIt’s time to honor your peers who are advancing diversity in leadership.OWL is pleased to accept nominations for the 2021…
On June 18, 2021, OWL and Alcon collaborated to host a virtual program “Eyes on Inclusion.” Coinciding with Pride Month,…
Rebecca Sanford serves as the Chief People Officer where she is responsible for building and leading talent management strategies and…
Developing leaders is OWL's mission and our specialty! Get terrific experience and benefit from the best-of-the-best networking in Ophthalmology when you get involved in OWL:
OWL is a 501(c)3 organization, meaning any financial contribution is 100% tax-deductible. OWL focuses the investment of members’ dues on programs and events that will benefit members (our admin costs are low compared to other nonprofits).
Your company can align with OWL's mission by having a presence at our events and benefit from exposure on our social mediachannels and in our member communications. Organizations and companies that want to be involved at the highest level can enroll their associates as virtual members, receive educational programs and get sponsorship exposure by becoming an OWL Partner.
LEARN MOREThe OWL Awards are given annually at OWL's Signature Event during AAO. The finalists are distinguished and respected - always an impressive group!
Nominations for the OWL Awards open in the Summer. A Nominations Committee selects the finalists and then OWL members cast their votes in the Fall.
Contact Us for information on nominating a colleague as a ‘Rising Star’, ‘Catalyst’ or ‘Visionary’ in Ophthalmology.
LEARN MORE
Assistant Professor of Ophthalmology & Associate Residency Program Director Cornea, Cataract & Refractive Surgery Baylor College of Medicine
Zaina Al-Mohtaseb, M.D. is an ophthalmologist specializing in cornea, external disease, cataract and refractive surgery. Dr. Al-Mohtaseb earned her medical degree with honors from Baylor College of Medicine. She completed her ophthalmology residency at the Cullen Eye Institute at Baylor College of Medicine and was elected Chief Resident. She finished her training at the University of Miami’s Bascom Palmer Eye Institute with a fellowship in cornea/external disease, cataract & refractive surgery. She is currently an associate professor at BCM. She has authored more than 40 peer reviewed scientific publications and book chapters and is an active peer-reviewer. She has taken an active leadership role and presents at multiple national and international conferences and has become a key opinion leader in ophthalmology. She truly enjoys education and is currently the associate residency director at BCM and is the incoming chair of the ASCRS Young Eye Surgeon committee. In her free time, she loves spending time with her husband Rami Farasin, daughter & son Aya & Zayd Farasin and her parents.
More OWL ChampionsChief Executive Officer TearLab Corporation
Seph Jensen, Chief Executive Officer of TearLab Corporation, is a seasoned leader with in-depth knowledge in the eye care category and a strong track record of delivering operational excellence and profitable growth.
Seph graduated from Flagler College in 1994 with a double major in business administration and marketing, and a minor in advertising. After leaving college, he joined ADP and became the top regional sales representative, and then moved to Jacksonville, FL to take a position with Warner Lambert.
In 1996, Seph joined Alcon Laboratories where he embarked on a 17-year tenure serving in the pharmaceutical and medical device sectors. He was appointed to various commercial positions in sales and marketing, including both local US markets and Japan. In 2012, Seph was promoted to the Head of Surgical Marketing and was responsible for over $1.4 billion in revenue.
In October 2013, Seph joined TearLab as the President and Chief Operating Officer. In 2016 he was promoted to Chief Executive Officer and led the company through a complete corporate and commercial restructure, cutting costs over 40% and growing the customer base by more than 25%. In July 2020, Seph negotiated the acquisition, privatization, and recapitalization of TearLab by the private equity investment firm, Accelmed. Under his leadership, TearLab is now well positioned to meet the growing market demand for innovation in the dry eye space.
More OWL Champions